SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

Skin & hair

Toenail Fungus: What Actually Works and What to Expect

Prescription oral antifungals — especially terbinafine — are the most effective treatment for toenail fungus (onychomycosis). Over-the-counter products penetrate the nail poorly and have limited success. Treatment takes months because the nail must grow out, and a confirmed diagnosis is recommended before starting oral medication.

Talk to a clinician

Nina Osei, NP — Nurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

What does toenail fungus look like?

Infected toenails typically change gradually over weeks to months. Recognizable signs include:

  • Thickening — the nail becomes harder to trim
  • Discoloration — yellow, brown, or white patches that start at the tip or side and spread inward
  • Brittleness or crumbling at the edges
  • Separation of the nail from the nail bed (onycholysis)
  • Debris under the nail — a powdery or crumbly accumulation
  • Mild odor in some cases

The big toenail and the little toenail are most commonly affected, but any toenail can be involved. Pain is not typical unless the nail becomes very thickened or a secondary bacterial infection develops.

Thickened or discolored nails do not always mean fungus. Nail trauma, psoriasis, and other conditions can look similar. Clinicians typically recommend confirming with a laboratory test before starting treatment, particularly before oral medication 1.

How common is toenail fungus?

Onychomycosis is one of the most common nail disorders. A 2024 systematic review of 108 studies with mycology-confirmed diagnoses estimated the prevalence of dermatophyte toenail onychomycosis in the general population at approximately 4% 2. Community-based surveys using clinical diagnosis suggest higher rates — around 8–10% globally. Prevalence increases substantially with age, diabetes, peripheral vascular disease, or immunosuppression; people with diabetes have roughly 2.8 times the risk of the general population 2.

Dermatophytes (primarily *Trichophyton rubrum*) cause the majority of cases, with yeasts and non-dermatophyte molds accounting for most of the remainder 2.

Why is toenail fungus hard to treat?

The nail plate is a dense, protective structure. Topical antifungals applied to the nail surface have difficulty penetrating to the nail bed where the fungus lives. This is why creams that work well for skin fungus (athlete's foot) have limited effect on nail infections.

Oral antifungals reach the nail bed through the bloodstream, which is why they outperform topical treatments for established infections — but they require a longer course and carry considerations around liver function monitoring.

Nails also grow slowly. Even after the fungus is eliminated, a visibly clear nail does not appear immediately — the new healthy nail has to grow out to replace the infected tissue. This typically takes six months to a full year for a toenail.

What over-the-counter options are available?

OTC antifungals have limited effectiveness for nail infections because they cannot penetrate the nail plate deeply enough to reach the nail bed.

Topical terbinafine (Lamisil AT cream/gel), tolnaftate, clotrimazole, miconazole: These work well for skin fungus but have poor nail penetration. They may help very early or superficial nail infections.

Vicks VapoRub: Contains thymol, eucalyptus oil, and menthol, which have demonstrated antifungal activity in vitro. A small pilot study (18 participants, 48 weeks) found 28% achieved complete mycological and clinical cure, and 56% showed partial clearance 3. The evidence base is modest — this was a case series, not a randomized trial — but the risk is low for those choosing to try it alongside other approaches.

Urea paste (high-concentration): Softens and thins the nail over time, potentially improving penetration for topical antifungals. Occasionally used as part of a combination approach.

OTC options are most worth considering for a single, mildly affected nail with less than half the nail involved and no significant thickening. If there is no visible improvement after three to six months of consistent OTC use, a clinician visit is warranted.

What prescription treatments work?

Oral terbinafine: Consistently shown to be the most effective single agent for toenail onychomycosis in systematic reviews and meta-analyses. A 2020 network meta-analysis of 26 randomized controlled trials (8,136 patients) found continuous terbinafine 250 mg daily significantly outperformed all topical agents for mycological cure 4. Clinical cure rates with a 12-week toenail course range from approximately 38–76% 1. A 2002 systematic review placed terbinafine above itraconazole, with a number needed to treat of 5 (treat 5 patients with terbinafine instead of itraconazole to gain one additional cure) 5.

A clinician will typically order baseline liver function tests before starting terbinafine. Hepatotoxicity is uncommon but has been reported, including rare serious cases — anyone with active liver disease may not be a candidate.

Oral itraconazole: Effective for infections caused by yeasts (*Candida*) and dermatophytes; sometimes used when terbinafine is not appropriate. Has more drug interactions than terbinafine. Clinical cure rates for a 12-week course range from approximately 14–63% 1.

Prescription topical nail lacquers: - *Efinaconazole 10% solution* (Jublia): Applied once daily for 48 weeks. Phase III trials showed complete cure rates of 15–18% and mycological cure rates of 53–55% 4. FDA-approved in 2014. - *Tavaborole 5% solution* (Kerydin): Applied once daily for 48 weeks. FDA-approved in 2014. - *Ciclopirox 8% lacquer*: Older topical option; complete cure rates of 6–9% at 48 weeks 1.

Prescription topicals penetrate the nail better than OTC creams and carry lower systemic risk than oral medications. They are most appropriate for mild to moderate infections or when oral antifungals are not suitable.

Laser treatment: Some dermatology practices offer laser devices. Evidence of efficacy is modest and not consistent across studies; not routinely covered by insurance. May be an option when oral antifungals are contraindicated.

Nail removal (surgical or chemical): Reserved for severe, refractory cases where direct treatment of the nail bed is needed. Rarely a first-line approach.

How long does treatment take, and what are realistic expectations?

Oral terbinafine for toenails is typically prescribed for 12 weeks. Even after completing the medication course, the nail will look infected until new, clear nail grows out — this process takes six to twelve months for a toenail.

Clinical cure (both laboratory clearance and a visibly normal nail) takes time. Topical treatments require 48 weeks of daily application before endpoints are measured.

Recurrence is a real consideration. One review estimated a relapse rate of 20–25% within two years of successful treatment 1. A five-year study found significantly lower relapse rates with terbinafine compared to itraconazole (23% vs. 53%) in severe disease. Post-treatment prophylaxis — twice-weekly topical antifungal applied after successful oral treatment — has been shown to reduce recurrence (33% vs. 76% without prophylaxis) 1.

Should a clinician confirm the diagnosis before treatment?

Testing before treatment — particularly before oral antifungals — is generally recommended. A positive laboratory result helps distinguish onychomycosis from nail trauma, psoriatic nail changes, or other conditions that can look identical but do not respond to antifungal treatment.

Two commonly used tests:

  • KOH preparation (potassium hydroxide microscopy): Clipped nail material is treated with KOH and examined under a microscope for fungal elements. Fast and inexpensive.
  • Fungal culture: Identifies the specific organism (dermatophyte, yeast, or mold), which can help guide treatment choice. Takes several weeks for results.
  • PAS stain of nail biopsy: A laboratory stain that is highly sensitive when other tests are inconclusive.

Before starting oral antifungals, a clinician will typically also check liver function tests to establish a baseline.

How to reduce the chance of toenail fungus coming back

Toenail fungus recurs in a meaningful proportion of people even after successful treatment. Several practical measures lower the risk:

  • Keep nails trimmed short and dry
  • Wear moisture-wicking socks and breathable footwear
  • Use antifungal powder or spray in shoes
  • Wear sandals or shower shoes in locker rooms, pool decks, and communal showers
  • Treat athlete's foot promptly — it frequently spreads to nails
  • Disinfect or replace old footwear that may harbor fungal spores
  • Ask a clinician about post-treatment topical prophylaxis

Common questions

Can toenail fungus go away on its own without treatment?

It is uncommon for established toenail fungus to clear without treatment. The fungus lives under the nail plate where the immune system has limited access. Mild, superficial infections occasionally improve, but most cases of thickened, discolored, or crumbling nails persist or worsen without antifungal treatment.

Is oral terbinafine safe?

Oral terbinafine is generally well tolerated. Gastrointestinal side effects are the most common complaint. Hepatotoxicity is uncommon but has been reported — rarely serious. Clinicians typically check liver function tests before prescribing, and the medication is not appropriate for people with active liver disease. A complete medication list matters, as terbinafine has some drug interactions. Itraconazole has more drug interactions and is used in specific situations.

How do I know if my nail is fungus or something else?

Nail trauma, psoriasis, and other conditions can look like toenail fungus. A KOH preparation or fungal culture from nail clippings can confirm the diagnosis. This is particularly worthwhile before starting oral antifungal medication, which carries some health considerations and takes several months to complete.

Why does toenail fungus keep coming back?

Recurrence happens for two reasons: relapse (surviving fungus regrows) or reinfection from the environment. Recurrence rates can reach 20–25% within two years of successful treatment. Using antifungal powder in shoes, wearing protective footwear in communal areas, treating athlete's foot, and considering post-treatment prophylactic topical antifungal use all reduce the risk.

Do topical treatments work as well as oral antifungals?

No — for established toenail infections, oral antifungals significantly outperform topical agents. A large network meta-analysis found continuous oral terbinafine or itraconazole had substantially greater odds of mycological cure than topical treatments. Prescription topical lacquers (efinaconazole, tavaborole) do work for mild to moderate infections, but complete cure rates with topicals at 48 weeks are lower than complete cure rates with oral treatment.

Talk to a clinician

Nina Osei, NP — Nurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

When to see a clinician promptly

  • —Nail infection accompanied by pain, swelling, or redness spreading to the surrounding skin — could indicate a secondary bacterial infection requiring separate treatment
  • —Diabetes or peripheral vascular disease: thickened or infected toenails raise the risk of serious foot complications including ulceration; prompt evaluation by a clinician or podiatrist is warranted
  • —A dark (brown or black) streak running lengthwise under a nail, or any streak that is widening or extends to surrounding skin — this needs evaluation to rule out subungual melanoma, not antifungal treatment
  • —Rapid or unexpected nail changes that do not fit the gradual pattern of fungus — evaluate to rule out other causes
  • —Signs of a systemic reaction during antifungal treatment: jaundice, dark urine, severe fatigue, or nausea — stop the medication and contact a clinician

This article is for general informational purposes only and does not constitute a diagnosis or personalized treatment recommendation. Toenail fungus can resemble other nail conditions; a clinician should confirm the diagnosis and guide treatment decisions, especially before starting oral antifungal medications.

References

  1. 1.Frazier WT, Santiago-Delgado ZM, Stupka KC II (2021). Onychomycosis: Rapid Evidence Review. American Family Physician. PMID 34652111 ✓Cure rate ranges for oral terbinafine and itraconazole; recurrence rates 20-25%; recommendation for confirmatory testing before treatment; post-treatment prophylaxis evidence
  2. 2.Gupta AK, Wang T, Polla Ravi S, Mann A, Bamimore MA (2024). Global prevalence of onychomycosis in general and special populations: An updated perspective. Mycoses. doi:10.1111/myc.13725 ✓Global dermatophyte toenail onychomycosis prevalence ~4% in community populations; elevated risk in diabetes (RR 2.8), geriatric patients (RR 4.7), immunosuppressed; dermatophyte predominance
  3. 3.Derby R, Rohal P, Jackson C, Beutler A, Olsen C (2011). Novel Treatment of Onychomycosis using Over-the-Counter Mentholated Ointment: A Clinical Case Series. Journal of the American Board of Family Medicine. doi:10.3122/jabfm.2011.01.100124 ✓Vicks VapoRub pilot study: 28% complete cure, 56% partial clearance at 48 weeks in 18 participants
  4. 4.Gupta AK, Foley KA, Mays RR, Shear NH, Piguet V (2020). Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis. British Journal of Dermatology. doi:10.1111/bjd.18155 ✓26 RCTs, 8,136 patients: continuous oral terbinafine and itraconazole significantly superior to topicals for mycological cure; efinaconazole complete cure 15-18%, mycological cure 53-55%
  5. 5.Crawford F, Young P, Godfrey C, Bell-Syer SEM, Hart R, Brunt E, Russell I (2002). Oral treatments for toenail onychomycosis: a systematic review. Archives of Dermatology. doi:10.1001/archderm.138.6.811 ✓Continuous terbinafine 250 mg daily for 3 months most effective oral treatment; NNT of 5 for terbinafine vs itraconazole

5 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.